X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-10-2024-93939.pdf
https://www.indianpharmapost.com/news/marksans-receives-usfda-approval-for-guaifenesin-extended-release-tablets-14565
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217780
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217340
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214407
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-26-2022-1643358623.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214781
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213420
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212542
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213420
https://www.moneycontrol.com/news/business/granules-india-gets-tentative-nod-from-usfda-for-expectorant-tablets-4940251.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210453
https://www.moneycontrol.com/news/business/markets/granules-india-jumps-6-on-establishment-inspection-report-from-usfda-for-bonthapally-unit-4430141.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2019-1561616031.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209692
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209254
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207342
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209692
https://www.fiercepharma.com/marketing/practical-magic-google-talks-about-how-digital-can-create-seamless-pharma-experiences
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208369
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209215
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209692
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pankaj-patel-owned-cadila-ups-its-india-game-with-azs-brands/articleshow/56734577.cms
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/61602r-eng.php
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208369
http://www.prnewswire.com/news-releases/perrigo-and-allergan-announce-first-to-market-launch-of-store-brand-otc-equivalent-to-mucinex-1200mg-dm-extended-release-tablets-300261741.html
http://www.prnewswire.com/news-releases/perrigo-and-allergan-announce-first-to-market-launch-of-store-brand-otc-equivalent-to-mucinex-1200mg-er-tablets-300240279.html
http://www.fiercepharma.com/story/perrigo-recalls-store-brands-popular-zyrtec-it-makes-cvs-kmart-and-others/2016-01-11
http://www.prnewswire.com/news-releases/not-all-cough-medications-are-equal-treato-finds-brands-matter-when-purchasing-over-the-counter-otc-cough-medications-300192937.html
http://www.prnewswire.com/news-releases/mission-pharmacal-introduces-two-new-cough-and-cold-medications-300181965.html
http://www.in-pharmatechnologist.com/Ingredients/Indian-firm-reconstructing-API-plant-after-being-hit-with-FDA-warning
http://www.prnewswire.com/news-releases/allergan-and-perrigo-receive-fda-approval-of-three-extended-release-products-equivalent-to-mucinex-and-mucinex-dm-300141198.html
https://www.pharmacompass.com/pdf/news/actaviss-generic-guaifenesin-12gm-approved-in-us-for-respiratory-tract-infections-1441796363.pdf
http://www.fiercepharma.com/story/reckitt-benckiser-makes-out-big-time-misery-us-flu-sufferers/2015-04-24?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.VTpbkSy8MSw.twitter
http://www.fiercepharmamanufacturing.com/story/labeling-foul-involving-acetaminophen-leads-rb-recall-135-lots-mucinex/2015-04-22
http://www.bloomberg.com/news/articles/2012-09-17/reckitt-benckiser-s-new-finance-chief-signals-strategic-shift
http://www.mmm-online.com/pfizer-challenges-novartis-otc-ad-claims/article/392121/?DCMP=EMC-MMM_Newsbrief&spMailingID=10367002&spUserID=NjU5NzQzMTk0MjkS1&spJobID=461003547&spReportId=NDYxMDAzNTQ3S0
http://www.prnewswire.com/news-releases/allergan-and-perrigo-announce-first-to-market-launch-of-store-brand-equivalent-to-mucinex-d-600mg-er-tablets-300198533.html
Market Place
Share 
